Skip to main content


Fig. 2 | Critical Care

Fig. 2

From: Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study

Fig. 2

Meropenem serum concentrations vs. time after last dose (n = 48 patients). Dark blue/red circles represent concentrations of patients treated with 1000 mg/2000 mg meropenem. Light blue/orange circles represent measured meropenem serum concentration values at the end of the actual dosing interval among patients treated with 1000 mg/2000 mg meropenem

Back to article page